Increased levels of growth factors and cytokines, such as GM-CSF, G-CSF, M-CSF, IL-6 and others, are commonly seen in cancer patients and mouse models, both systemically or in the tumor microenvironment (59–61). This evidence concerns the gene CSF2 and cancer.